Buffalo General joins New York City-based Mount Sinai Health System and Pittsburgh-based UPMC as health systems participating in the trial, according to a March 20 Synchron news release.
The Command Trial will primarily focus on safety while also beginning to assess the efficacy of the Synchron Switch, a brain-computer interface device designed to allow people with limited or no mobility to control technology using their thoughts.
The FDA granted breakthrough device designation to Synchron in August 2020.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
